ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+11.31%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$311M
AUM Growth
+$69M
(+29%)
Cap. Flow
+$48.5M
Cap. Flow
% of AUM
15.58%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
105
New
32
Increased
29
Reduced
26
Closed
17
Top Buys
| 1 |
Universal Health Services
UHS
|
$11.8M |
| 2 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$8.6M |
| 3 |
VWR
VWR Corporation
VWR
|
$7.23M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$6.58M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$6.49M |
Top Sells
| 1 |
STJ
St Jude Medical
STJ
|
$9.69M |
| 2 |
Encompass Health
EHC
|
$5.54M |
| 3 |
SHPG
Shire pic
SHPG
|
$4.89M |
| 4 |
McKesson
MCK
|
$4.63M |
| 5 |
Hologic
HOLX
|
$3.42M |
Sector Composition
| 1 | Healthcare | 86.32% |
| 2 | Financials | 3.19% |
| 3 | Industrials | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Regeneron Pharmaceuticals
REGN
$59.8B
| $504K | 0.16% |
1,300
-900
| -41% | -$349K |
|
77
Regenxbio
RGNX
$498M
| $479K | 0.15% |
+24,800
| New | +$479K |
|
78
BioMarin Pharmaceuticals
BMRN
$11.3B
| $448K | 0.14% |
+5,100
| New | +$448K |
|
79
Cigna
CI
$80.2B
| $439K | 0.14% |
3,000
-20,150
| -87% | -$2.95M |
|
80
HCA Healthcare
HCA
$95.4B
| $379K | 0.12% |
4,262
-32,838
| -89% | -$2.92M |
|
81
Corvus Pharmaceuticals
CRVS
$419M
| $282K | 0.09% |
+13,600
| New | +$282K |
|
82
AnaptysBio
ANAB
$630M
| $258K | 0.08% |
+9,300
| New | +$258K |
|
83
SPDR S&P Biotech ETF
XBI
$5.29B
| $243K | 0.08% |
+3,500
| New | +$243K |
|
84
Bausch Health
BHC
$2.72B
| $221K | 0.07% |
+20,000
| New | +$221K |
|
85
Exelixis
EXEL
$9.95B
| $214K | 0.07% |
9,870
-51,000
| -84% | -$1.11M |
|
|
ONCE
86
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $213K | 0.07% |
4,000
-10,800
| -73% | -$575K |
|
|
OCRX
87
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $200K | 0.06% |
152,642
-73,800
| -33% | -$96.7K |
|
88
Acadia Healthcare
ACHC
$2.15B
| – | – |
-44,800
| Closed | -$1.48M |
|
89
Amgen
AMGN
$153B
| – | – |
-4,358
| Closed | -$637K |
|
90
Baxter International
BAX
$12.1B
| – | – |
-4,700
| Closed | -$208K |
|
|
CBIO
91
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| – | – |
-145
| Closed | -$88K |
|
92
Henry Schein
HSIC
$8.14B
| – | – |
-54,060
| Closed | -$3.22M |
|
93
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-11,500
| Closed | -$445K |
|
94
Penumbra
PEN
$10.5B
| – | – |
-49,500
| Closed | -$3.16M |
|
95
VanEck Pharmaceutical ETF
PPH
$625M
| – | – |
-15,600
| Closed | -$819K |
|
96
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-8,400
| Closed | -$230K |
|
97
Steris
STE
$23.9B
| – | – |
-16,600
| Closed | -$1.12M |
|
|
ENDP
98
DELISTED
Endo International plc
ENDP
| – | – |
-44,196
| Closed | -$728K |
|
|
MDCO
99
DELISTED
Medicines Co
MDCO
| – | – |
-27,300
| Closed | -$927K |
|
|
ARRY
100
DELISTED
Array Biopharma Inc
ARRY
| – | – |
-28,100
| Closed | -$247K |
|